Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

This study has been terminated.

Study NCT00023166 Information provided by Enzon Pharmaceuticals, Inc.

First Received: August 24, 2001 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	May 2002
Estimated Primary Completion Date:	No date given